Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue shar
(Financial Post, 2025-11-03T12:45:43Z)